fbpx Skip to main content

According to this study, minorities are less likely to seek healthcare intervention for eczema despite having more severe cases.

Eczema, also known as atopic dermatitis (AD), is a common chronic inflammatory disease of the skin. Based on information from this cohort study published in the Journal of American Academic Dermatology, in the United States, eczema affects  17.1% of non-Hispanic Black children, 11.2% of non-Hispanic White children, and 13.7% of Hispanic White children. However, there is limited research on how much healthcare is utilized for black children who suffer from eczema.

The study examined healthcare utilization for childhood eczema among different racial/ethnic groups in the United States and included a multi-racial group of 2043 participants. Non-Hispanic Whites, non-Hispanic Blacks, and Hispanic Whites under 18 years of age with caregiver-reported eczema made up the study group. Data for this study was retrieved from 2-year longitudinal cohorts of the 2001-2013 Medical Expenditure Panel Surveys. During the 2-year follow-up period, healthcare utilization outcomes were assessed by race/ethnicity.

More Prescriptions Were Needed for Non-Hispanic Black Patients 

Non-Hispanic Blacks were less likely than Whites to report an ambulatory visit for eczema among all children with eczema. It also found that among the study participants with ≥1 ambulatory visit for eczema, non-Hispanic Blacks reported more visits and prescriptions than Whites. They were also more likely than Whites to report a dermatology visit for eczema.

Underutilization of Healthcare Among Black Children With Eczema Was Noted

This study’s results suggested that even though this skin condition can be more severe for non-Hispanic Black children, Black children with eczema utilize healthcare options less frequently. 

This study did have some limitations. Only self-report or caregiver report was used for eczema identification. 

You May Also Like::  Patient's Mental Health Impacts Rating of Psoriasis Severity

Other research studies and literature reviews have explored the direct and indirect barriers to healthcare utilization for minorities. However, further exploration is needed regarding effective ways to reduce these barriers for increased healthcare utilization in minority populations.


Fischer, A. H., Shin, D. B., Margolis, D. J., & Takeshita, J. (2017). Racial and ethnic differences in health care utilization for childhood eczema: An analysis of the 2001-2013 Medical Expenditure Panel Surveys. J Am Acad Dermatol, 77(6), 1060-1067. https://doi.org/10.1016/j.jaad.2017.08.035


“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More